Vera-Leiva, Alejandra <br/><br/>
The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.  [electronic resource] 

 -  Journal of global antimicrobial resistance  03 2018 
 - 73-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-7173 
<br/><br/><label>Standard No.: </label>10.1016/j.jgar.2017.12.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Bacterial Outer Membrane Proteins--analysis<br/>Bacterial Proteins--metabolism<br/>Biological Transport, Active--drug effects<br/>Carbapenem-Resistant Enterobacteriaceae--drug effects<br/>Carbapenems--pharmacology<br/>Chile<br/>Dipeptides--metabolism<br/>Electrophoresis, Polyacrylamide Gel<br/>Enzyme Inhibitors--metabolism<br/>Gene Expression Profiling<br/>Humans<br/>Klebsiella Infections--microbiology<br/>Klebsiella pneumoniae--chemistry<br/>Membrane Transport Proteins--metabolism<br/>Microbial Sensitivity Tests<br/>Real-Time Polymerase Chain Reaction<br/>beta-Lactamases--metabolism